The University of Chicago Header Logo

Connection

Daniel Shevrin to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Daniel Shevrin has written about Randomized Controlled Trials as Topic.
Daniel Shevrin
Connection Strength
0.070
Randomized Controlled Trials as Topic
  1. Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non-muscle-invasive Bladder Cancer (BRIDGE). Eur Urol Focus. 2023 07; 9(4):561-563.
    View in: PubMed
    Score: 0.042
  2. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel. J Clin Oncol. 2018 02 01; 36(4):376-382.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.